Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-02-27 @ 4:06 PM
Study NCT ID:
NCT00552058
Status:
COMPLETED
Last Update Posted:
2018-08-09
First Post:
2007-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Sponsor:
UCB Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-18
First Submit QC Date:
None
Study First Post Date:
2007-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-08
Results First Submit QC Date:
None
Results First Post Date:
2010-12-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-10
Last Update Post Date:
2018-08-09
Last Update Post Date Type:
ACTUAL